Jefferies sets Synovus stock price target at $55, starts at Hold

Published 20/05/2025, 22:30
Jefferies sets Synovus stock price target at $55, starts at Hold

Tuesday, Jefferies initiated coverage on Synovus Financial (NYSE:SNV) shares with a Hold rating, setting a price target of $55.00. The financial research firm acknowledged Synovus’ significant market presence in the lucrative Southeastern regions of the United States and its potential for increased fee income. The $6.79 billion market cap bank currently trades at $48.88, with InvestingPro analysis indicating the stock is slightly undervalued based on its Fair Value model.

In their coverage initiation, Jefferies analysts pointed to Synovus’ history of loan losses that have, at times of economic pressure, surpassed those of its peers. They noted that while Synovus has improved its risk profile considerably since the Global Financial Crisis (GFC), there are concerns about its loan losses. Despite these concerns, InvestingPro data shows the company maintains a GOOD Financial Health Score of 2.57, with 12 analysts recently revising earnings estimates upward.

The firm also mentioned Synovus’ below-average capital levels, suggesting that this could pose challenges for the company, especially in an uncertain economic climate. Jefferies’ valuation reflects a cautious stance on the bank’s financial health amid these potential risks. However, the bank has demonstrated financial resilience, maintaining dividend payments for 52 consecutive years and currently trading at an attractive P/E ratio of 13.7x.

The price target of $55.00 implies Jefferies’ expectation for the stock’s performance. It serves as a reference for investors considering Synovus shares while weighing the bank’s strong market position against the risks identified by the analysts.

Synovus Financial, with its strong foothold in growth-oriented Southeastern markets, will continue to navigate the financial landscape while investors and market watchers observe how it manages the balance between growth opportunities and the risks outlined by Jefferies. For deeper insights into Synovus’ financial health and growth prospects, investors can access comprehensive analysis and additional ProTips through InvestingPro’s detailed research reports.

In other recent news, Synovus Financial reported its first-quarter 2025 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $1.30, compared to the forecasted $1.12. The company also reported revenue of $570.9 million, slightly exceeding projections. Analysts from DA Davidson, Stephens, and BofA Securities have weighed in on the company’s performance. DA Davidson maintained a Buy rating, while reducing its price target to $60, highlighting Synovus’ solid start to the year and effective expense management. Stephens, on the other hand, lowered its price target to $46 but kept an Equal Weight rating, noting the company’s core pre-provision net revenue surpassed consensus estimates. Meanwhile, BofA Securities raised its price target to $60, maintaining a Buy rating, following Synovus’ outperformance relative to peers and a notable expansion in net interest margin. The company’s revised fiscal guidance includes adjustments to expense growth and stable revenue forecasts, indicating a carefully managed financial strategy amidst broader economic conditions. These developments reflect Synovus Financial’s ongoing efforts to maintain financial stability and growth in a fluctuating market environment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.